These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18489711)

  • 21. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?
    Warkentin TE; Sheppard JA; Moore JC; Moore KM; Sigouin CS; Kelton JG
    J Lab Clin Med; 2005 Dec; 146(6):341-6. PubMed ID: 16310517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT.
    Warkentin TE; Arnold DM; Sheppard JI; Moore JC; Kelton JG; Nazy I
    J Thromb Haemost; 2023 Aug; 21(8):2268-2276. PubMed ID: 37182698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of an IgG-Specific Enzyme-Linked Immunosorbent Assay Cutoff of 0.4 Versus 0.8 and 1.0 Optical Density Units for Heparin-Induced Thrombocytopenia.
    Ritchie BM; Connors JM; Sylvester KW
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):282-286. PubMed ID: 26400659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.
    Greinacher A; Pötzsch B; Amiral J; Dummel V; Eichner A; Mueller-Eckhardt C
    Thromb Haemost; 1994 Feb; 71(2):247-51. PubMed ID: 8191407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia.
    Althaus K; Hron G; Strobel U; Abbate R; Rogolino A; Davidson S; Greinacher A; Bakchoul T
    Thromb Res; 2013 Mar; 131(3):e85-90. PubMed ID: 23351665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pitfalls in the diagnosis of heparin-Induced thrombocytopenia: A 6-year experience from a reference laboratory.
    Nazi I; Arnold DM; Moore JC; Smith JW; Ivetic N; Horsewood P; Warkentin TE; Kelton JG
    Am J Hematol; 2015 Jul; 90(7):629-33. PubMed ID: 25809312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia.
    McFarland J; Lochowicz A; Aster R; Chappell B; Curtis B
    Am J Hematol; 2012 Aug; 87(8):776-81. PubMed ID: 22641378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities.
    Warkentin TE; Sheppard JA; Chu FV; Kapoor A; Crowther MA; Gangji A
    Blood; 2015 Jan; 125(1):195-8. PubMed ID: 25406354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
    Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
    J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study.
    Selleng S; Selleng K; Friesecke S; Gründling M; Kuhn SO; Raschke R; Heidecke OJ; Hinz C; Hron G; Warkentin TE; Greinacher A
    J Thromb Thrombolysis; 2015 Jan; 39(1):60-7. PubMed ID: 25002339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
    Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
    J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem.
    Raschke RA; Curry SC; Warkentin TE; Gerkin RD
    Chest; 2013 Oct; 144(4):1269-1275. PubMed ID: 23703622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia.
    Bissola AL; Daka M; Arnold DM; Smith JW; Moore JC; Clare R; Ivetic N; Kelton JG; Nazy I
    Blood Adv; 2022 Jul; 6(14):4228-4235. PubMed ID: 35609563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory testing for VITT antibodies.
    Warkentin TE; Greinacher A
    Semin Hematol; 2022 Apr; 59(2):80-88. PubMed ID: 35512905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients.
    Berry C; Tcherniantchouk O; Ley EJ; Salim A; Mirocha J; Martin-Stone S; Stolpner D; Margulies DR
    J Am Coll Surg; 2011 Jul; 213(1):10-7; discussion 17-8. PubMed ID: 21531584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of clinical and laboratory data for early diagnosis of heparin-induced thrombocytopenia.
    Bayat M; Macedo FY; Ansari AS; Bracey AW; Akinyele S; Salazar M
    Am J Health Syst Pharm; 2015 Oct; 72(19):1649-55. PubMed ID: 26386106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective observational evaluation of the particle immunofiltration anti-platelet factor 4 rapid assay in MICU patients with thrombocytopenia.
    Andrews DM; Cubillos GF; Paulino SK; Seckinger DL; Kett DH
    Crit Care; 2013 Jul; 17(4):R143. PubMed ID: 23876263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay.
    Warkentin TE; Sheppard JI; Smith JW; Arnold DM; Nazy I
    Int J Lab Hematol; 2019 Aug; 41(4):493-502. PubMed ID: 31050876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.